Upstream Bio to Host Conference Call and Webcast to Report Top-Line Data from the Phase 2 VIBRANT Trial of Verekitug in Patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
WALTHAM, Mass., Sept. 01, 2025 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq:…
Cognizant to Deploy 1,000 Context Engineers, Powered by ContextFabric, to Industrialize Agentic AI
Cognizant and Workfabric AI join forces to create a new discipline that…
Vaxart Granted Extension by Nasdaq to Regain Compliance
August 29, 2025 08:00 ET | Source: Vaxart, Inc. - Company must…
Praxis Precision Medicines to Participate in Upcoming Fireside Chat
BOSTON, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ:…
Aurora Mobile Limited Announces Second Quarter 2025 Unaudited Financial Results
SHENZHEN, China, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (“Aurora…
FN7/2025 Halvrsmeddelelse – egenkapital genetableret og strk ordreindgang
NASDAQ FIRST NORTH GROWTH MARKET MEDDELELSE NR. 7/2025 København, den 28. august…
CTW to Participate in the Lake Street 2025 BIG9 Conference
TOKYO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- CTW Cayman (Nasdaq: CTW) (“CTW”…
NETSOL Chosen by Sonic Automotive to Power Next-Gen Digital Retail Experience
ENCINO, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- NETSOL Technologies, Inc. (Nasdaq:…
VMware Cloud Foundation Elevates Cyber Resilience, Compliance, and Security for the Modern Private Cloud
New VCF and Advanced Services Innovations Address Compliance Complexities in Regulated Industries…
Praxis Medicines to Present at 36th International Epilepsy Congress 2025 in Lisbon, Showcasing Latest RADIANT Study Data and Leading Precision Epilepsy Pipeline
BOSTON, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ:…